Frontiers in Alzheimer's Disease Research -

Frontiers in Alzheimer's Disease Research

E M Welsh (Herausgeber)

Buch | Hardcover
353 Seiten
2006
Nova Science Publishers Inc (Verlag)
978-1-59454-929-8 (ISBN)
226,75 inkl. MwSt
Dementia is a brain disorder, and the most common form of dementia among older people is Alzheimer's Disease (AD). This book gathers research from scientists throughout the world which offers information on understanding the underlying causes and discovering effective treatments for Alzheimer's Disease.
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control memory, thought and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory loss and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk for developing it, improving the accuracy of diagnosis and ability to identify who is at risk, developing, discovering and testing new treatments for behavioural problems in patients with AD. This book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.

Preface; Inflammatory, Oxidative and Vascular Factors Affecting Neuronal Cell Death in Alzheimer's Disease; Neuronal Cell Death in Alzheimer's Disease and its Potential Therapy with Neuroprotective Factors; Synapse and Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease; Neuropsychological Manifestations in Preclinical Alzheimer's Disease; Altered Brain Activation During Cognitive Process in Alzheimer's Disease; Premature Centromere Division (PCD) of the X Chromosome as a Bio Marker of the Brain Cells Re-entry into the Cell Division Cycle in Alzheimer's Disease; The Aging Brain: The Risk Factor for Sporadic Alzheimer's Disease (SAD). Cellular and Molecular Aspects ; Remembering Emotional Information: Effects of Aging and Alzheimer's Disease; APOE, Anxiety and Alzheimer's Disease; Insulin Resistance, Depressive Disorders and Alzheimer's Disease; Searching for Genetic Risk Factors in AD: A Never-Ending Story; APOE and Cognitive Function in Non-demented Old Age: A Genetic Basis for Brain or Cognitive Reserve?; Index.

Erscheint lt. Verlag 13.8.2006
Zusatzinfo Illustrations
Verlagsort New York
Sprache englisch
Maße 260 x 180 mm
Gewicht 870 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
ISBN-10 1-59454-929-X / 159454929X
ISBN-13 978-1-59454-929-8 / 9781594549298
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
33,00
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
189,00
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
37,00